HSIC
HSIC
US8064071025
Henry Schein, Inc.
Loading chart...

Company Profile

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Latest News

Related stocks

COR
COR • United States
Cencora, Inc.
323.85 USD
61.8B USD 1Y +3.5%
CAH
CAH • United States
Cardinal Health, Inc.
237.57 USD
55.01B USD 1Y +51.5%
MCK
MCK • United States
McKesson Corporation
938.84 USD
109.46B USD 1Y +23.1%
1099.HK
1099.HK • China
SINOPHARM
14.87 HKD
5.91B USD 1Y -20.5%
601607.SS
601607.SS • China
SHANGHAI PHARMACEUTICALS HOLDIN
16.68 CNY
9.26B USD 1Y -8.8%
AMP.MI
AMP.MI • Italy
AMPLIFON
12.86 EUR
3.83B USD 1Y -20.6%
ASKER.ST
ASKER.ST • Sweden
Asker Healthcare Group AB
68.85 SEK
2.64B USD 1Y -20%
GALE.SW
GALE.SW • Switzerland
GALENICA N
85.2 CHF
5.11B USD 1Y -4.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
25.4% p.a.
Max Drawdown (5Y)
-32.7%
Sharpe Ratio (5Y)
-0.05
Beta Factor
0.84
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
ende